In this article, we show that the surface of the bacteriophage Qβ is equipped with natural ligands for the synthesis of small gold nanoparticles. By exploiting disulfides in the protein secondary structure and the geometry formed from the capsid quaternary structure, we find we can produce regularly arrayed patterns of 6 nm gold nanoparticles across the surface of the virus-like particle. Experimental and computational analysis provide insight into the formation and stability of this composite. We further show that the entrapped genetic material can hold upwards of 500 molecules of the anti-cancer drug Doxorubicin without leaking and without interfering with the synthesis of the gold nanoparticles. This direct nucleation of nanoparticles on the capsid allows for exceptional conduction of photothermal energy upon nanosecond laser irradiation. As a proof of principle, we demonstrate that this energy is capable of rapidly releasing the drug from the capsid without heating the bulk solution, allowing for highly targeted cell killing in vitro. 
INTRODUCTION
The explosive growth in the synthesis of inorganic materials, specifically plasmonic gold nanoparticles (AuNPs) with controlled nanostructures, has led to a number of divergent applications in the biomedical and materials fields. [1] [2] [3] [4] [5] [6] [7] Amongst the possible strategies to create homogenously sized AuNPs, biomolecular templates such as proteins, 8 nucleic acids, 9-10 biological fibers, 11 and lipids [12] [13] have emerged owing to the ordered and well-defined structures these macromolecules form. In addition to these structural advantages, the utilization of bio templates can impart additional characteristics to these nanomaterials, including solution stability, three-dimensional architectures, molecular and cellular recognition, and tunability for optimized cell uptake. [14] [15] [16] [17] These emergent characteristics permit advanced applications like concomitant drug delivery and in vivo imaging.
Virus-Like Particles (VLPs), 18 the non-infectious [19] [20] proteinaceous nanoparticle analogues of viruses, are proven templates [21] [22] [23] for the synthesis of metal nanoparticles as they are innately monodisperse in size and can be genetically modified 24 25 or chemically functionalized [26] [27] [28] to attach stabilizing ligands or residues onto their surface with atomistic precision. While there have been several instructive reports on coating 29 , absorbing [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] or growing large AuNPs 5, 21-22, 39-43 onto or within viral capsids using surface exposed residues, reports on restricting the diameter of the nanoparticles by constraining their growth to a homogenous sub-7 nm size have not been forthcoming. This is an important issue because nanoparticle size is critically linked to clearance from blood and tissues. 44 While the exact maximum size of a nanoparticle that can be cleared from the body effectively is hard to pin down, it is generally accepted that particles with a diameter greater than 8 nm are too large to pass through the glomerulus of the kidney. 45 Consequently, with no way to leave the body, these materials become trapped in highly vascular tissues and organs of the reticuloendothelial system. 46 This is unfortunate, as nanoparticles over 20 nm in diameter appear to have the innate capability of localizing in certain tumors 47 through the enhanced permeability and retention (EPR) effect. 48 Researchers have thus found themselves stuck between two irreconcilable size constraints-inorganic nanoparticles large enough to exploit the EPR effect are too large to be filtered through the kidney and thus accumulate in the body. To address this problem, we seek to utilize a multivalent strategy to decorate a proteinaceous VLP that degrades in the liver 49 with multiple small plasmonic AuNPs such that the individual nanoparticles are below the kidney's theoretical cutoff yet, as an ensemble, are large enough to exploit the EPR effect. From here, these small clustered AuNPs could serve as X-ray or PET contrast agents 50 as well as photothermal antennae for an external stimulus to activate drug release or sensing. Indeed, the growth of AuNPs directly onto the protein surface should increase the efficiency of thermal conduction following laser induced heating. This improved transfer of thermal energy into the protein by direct templated-growth should cause thermally induced protein denaturation more efficiently compared to traditional methods to attach gold onto protein surfaces via bioconjugated spacers or synthetic ligands. 51 In principle, this would mean the amount of gold necessary to induce any changes in protein structure could be reduced, decreasing the likelihood of detectable bioaccumulation even further. In this paper, we report the synthesis and characterization of such a system using VLP Qβ as outlined in Scheme 1. The Qβ capsid itself is an icosahedral virus with 180 identical coat proteins and contains 32 disulfide lined pores. 52 We reasoned that these proteins, linked like a daisy chain by either five or six disulfides to form a fixed pore, would act as a natural ligand [53] [54] and template for the formation of spherical gold nanoparticles upon in situ reduction of gold salts. We then show that this new composite material works as a proof-ofprinciple photolytically activated drug delivery vehicle. We can load the capsid with the anticancer drug Doxorubicin (Dox) by non-covalently binding it to the random RNA located within the capsid, grow gold nanoparticles over the loaded VLP and, finally, initiate release of the RNA-bound Dox from the center of the virus using nanosecond laser irradiation to disrupt the proteinaceous shell and release the drug molecules from the interior. Furthermore, we are able to demonstrate highly selective drug release and cell killing in vitro exclusively within the laser path while cells outside the path-even though they are in the same culture-survive.
Scheme 1: Qβ possesses 32 pores, each either 1.5 or 3.0 nanometers in diameter, which are large enough to permit A) the diffusion of Doxorubicin into and out of the VLP; after loading, the pores are then B) capped by ~6 nm AuNPs grown in situ.
RESULTS AND DISCUSSION

Synthesis and Characterization of AuNP@Qβ
The Qβ VLP, structurally depicted in Figure 1 , is expressed as a non-infectious nanoparticle that self-assembles around random genomic material within E. coli. Protein crystallographic analysis reveals 20 pores at the three-fold axis and 12 smaller pores at the five-fold axis of symmetry. Key to our strategy is that these pores are lined with solvent exposed disulfides and we hoped to benefit from the affinity of disulfides toward gold species. To establish an optimized protocol for site-specific growth of AuNPs, parameters including the concentrations of Qβ and tetrachloroauric acid, reaction temperature, and incubation time were individually varied until we had minimized the formation of unstable naked gold particles. After significant optimization, the required conditions for AuNP formation turned out to be quite straightforward-specific absorption of gold by disulfide bonds was achieved by incubating Qβ and tetrachloroauric acid in water followed by addition of the reducing agent sodium borohydride. Because the water was unbuffered, the final solution was lowered to a pH of 2 by the gold acid as an alternative pH 7 0.1 M Potassium Phosphate buffer was used. Once all the reagents were added to the vial, the solution was allowed to sit undisturbed for at least 2 hours, during which time it quickly went from light to dark red ( Figure S1 ). Based upon UV-Vis kinetic analysis following the formation of the surface plasmon, the reaction is 50% complete after 5 min and >99% complete after 20 min ( Figure S2 ). After the reaction, the small amount of precipitated and unbound gold nanoparticles were removed from the crude mixture by passing the reaction solution through a size exclusion column. We noted that the nanoparticles in the precipitate increases as we increased the concentration of the acidic gold starting material, which we attribute to a decrease in pH and concomitant protein aggregate formation, which can no longer function as a template.
FIGURE 1:
The Qβ VLP is depicted as ribbon model. The VLP has a diameter of 28 nm and contains a total of 32 pores. Depicted are one of the 20 large pores, each of which contains six disulfide bonds, and one of the 12 smaller pores, each of which contains five disulfide bonds.
The selective growth of AuNPs on the pore structures was verified by transmission electron microscopy (TEM) (Figures S3 and S4 ), which indicated that nearly every VLP contained some population of AuNPs, though it appeared that there was a fairly wide distribution of the number of AuNPs per Qβ. The nanoparticle population dispersity prompted an investigation into the average number of nanoparticles per capsid, which was determined to be approximately 6 ± 3 per Qβ ( Figure S5 ) as determined by ICP-MS. DLS found an increase in capsid size from 23 nm to 64.83 ± 0.219 nm, a significant increase in the size of the capsid ( Figure S19 ). Negative stain was used to show the position of Qβ relative to the AuNPs. A crystallographic model of Qβ was used to map the AuNPs over the surface. The micrographs shown in Figure 2 exhibit excellent correlation to the mapped pore patterns on the right. This clear association of the AuNPs to the pore locations strongly suggests that the pores themselves both selectively nucleate and control the final diameter of the AuNPs. The AuNPs appear fairly monodisperse in size by TEM with a diameter of 3.6 ± 1 nm, smaller than the theoretical cutoff limit of the glomerulus of the kidney. Powder X-ray diffraction confirmed the crystallinity of the as-synthesized AuNPs in the AuNP@Qβ composite and Rietveld refinement of the data was used to confirm that the bulk as-synthesized diameters of the AuNPs is 6.2 ± 0.2 nm. Regardless, both values are within published cutoff limits for glomerular filtration. In addition, X-ray powder diffraction showed the structure type of the AuNP is face centered cubic with the space group Fm3m ( Figure S6 ). The AuNP@Qβ solution is a deep red color and UV-vis spectra shows an absorption centered at 526 nm, which corresponds to the surface plasmon ( Figure 2B ). To elucidate the role of the virus in the nucleation and growth of the AuNPs, we conducted several control experiments. When the same procedure was performed in the absence of any Qβ, a dark precipitate formed in solution. This precipitate was collected and was found to be spherical gold nanoparticles as determined by X-Ray diffraction and confirmed by TEM, with a diameter of 48 ± 10 nm as ( Figure S6 ). To confirm that the disulfides themselves were responsible, we prepared a solution of Qβ and first reduced the disulfides to the free thiols and then alkylated them with 2-iodoacetimide. We obtained the same results as when no Qβ was present in the solution-huge particles in a black precipitate -confirming the role of the disulfides in the controlled nucleation ( Figure S1 ). In our initial strategy, we assumed that reduction of the disulfides was occurring with sodium borohydride, but we were able to rule this out as we detected no such reduction by gel electrophoresis ( Figure S8 ) nor was there any appreciable difference in the Ellman's assay before and after addition of borohydride ( Figure S10 ). It is important to point out that, during the synthesis, even spectroscopically pure virus particles are not fully oxidized-that is to say, it appears from non-reducing SDS-PAGE that monomeric proteins exist when there should be none [55] [56] ( Figure S9 ). Curiously, reducing the disulfides to free sulfurs also fails to yield AuNP formation on the surface of the virus. Nevertheless, based on these experiments, it is quite evident that nucleation and size control is occurring as a result of the disulfide and pore geometry as we get uncontrolled particle growth in their absence.
AuNP@Qβ are stable at room temperature for more than a month when left undisturbed on the bench. TEM micrographs ( Figure S11 ) of a month-old sample that had been left under ambient laboratory conditions show the AuNPs still associated with Qβ, and neither free AuNPs nor aggregation was visible. This stability is surprising considering that (1) the nanoparticles are considerably larger than the pores and (2) there are only 10 or 12 sulfurs bound to the nanoparticle. Based on the TEM data, which show varying levels of contrast on the edges of the nanoparticles, we anticipated that there were interactions between the virus and the nanoparticles beyond simply Au-S bonding. We thus conducted computational analysis to determine the likely changes in the local environment around the nanoparticle. As seen in Figure 3 , we modeled a 6.4 nm nanoparticle bound to the twelve sulfurs of the hexameric pore structure. Molecular Dynamics (MD) simulations provide a reasonable picture of the actual nanoparticle-protein interaction. From these simulations several intriguing results could be inferred (See the expanded discussion of the theory in SI and Figures S12-S15). Interestingly, there was no significant change in the size of the hexameric pore.).
However, the pore sulfurs shifted radially inward, which created a deeper cavity for the nanoparticle to sit in and, as shown in Figure 3 , allowed more of the loop structures present near the pore to cover the surface of the nanoparticle. Roughly 23% of the nanoparticle's surface area was protected by surrounding proteins, which does not significantly change the secondary structure of the VLP as shown by circular dichroism (CD) measurements ( Figure 4D ). The stability provided by the surrounding proteins makes sense, as 6 nm naked gold nanoparticles are unstable and subject to rapid Ostwald ripening resulting in precipitation. 41, 42 Being embedded in the virus coat protein not only stabilizes but also protects these particles-see supplemental information for an explanation based on classical nucleation theory and an analysis of the smaller five membered pores. Gold nanoparticles are well known photothermal agents and are among the best materials for converting incident optical energy into heat. 44 This heat can be dissipated diffusely into the environment by continuously irradiating the sample, which results in a heating of the bulk solution. Alternatively, heat can be generated very locally by pulsed irradiation causing the surface of the nanoparticle to heat to several hundred degrees without significantly heating the bulk solution. 45 More than a decade ago, this latter form of pulsed irradiation was found to selectively denature proteins 46 though, recently, the controlled application of photothermal irradiation to control protein or nucleotide function without damaging the cell has emerged as a potent method of manipulating specific cells 51, 57 . Because the growth of the AuNP occurs directly onto the surface of the protein, we reasoned that-even without 100% gold coverage on each VLP-we would be able to induce a photothermal response using modest laser power due to close proximity of AuNP and protein shell. We thus sought to determine if this mechanism could induce the disruption of the protein shell, triggering release of entrapped small molecule drugs. This would enable very localized drug release within a tumor environment without damaging nearby healthy cells.
Laser Activated Drug Delivery
To do this, we exploited the fact that the self-assembly of recombinant Qβ occurs around random genomic material within E. coli. We hypothesized that this genetic material could be used as a supramolecular host capable of non-covalently trapping the strong nucleotide intercalator Doxorubicin (Dox)-a fluorescent chemotherapeutic used in many different cancer therapies. Binding of Dox to VLP RNA is not without precedent as researchers have shown 47 that the RNA inside the red clover necrotic mosaic virus capsid tightly holds upwards of 4300 molecules of Dox. Our tests show that the genetic material inside Qβ does the samewhen Dox is bound inside the VLP the fluorescence in quenched (Figures 4 A-C and S16) and when it is released it fluoresces. The association for Dox to the nucleic acids inside the Qβ is sufficiently high that after loading, we observe no leakage, even after 24 hours ( Figure S17 ). Thus, we can monitor release by following any fluorescence enhancement after laser irradiation.
To create the Dox loaded, gold bespeckled, viral nanoparticles, we followed a procedure outlined in Scheme 1. Initially, the Qβ is loaded by incubating the VLP in a 1 mg/mL solution of Dox for 10 min at room temperature. This mixture is then filtered through a GE Sephadex G-25 size exclusion column to remove unbound Dox to create Qβ(Dox). ( Figure  S18 ) The filtered solution of Qβ(Dox) was then subjected to the same procedure to grow AuNPs over the surface. This solution was again passed through a GE Sephadex G-25 size exclusion column to remove unattached nanoparticles and excess salts to yield pure AuNP@Qβ(Dox). By TEM, we saw no discernable difference in gold loading over the pores nor any changes in nanoparticle sizes. We were pleased to see that we could load upwards of 500 molecules of Dox-as determined by UV-Vis spectroscopy-without interfering with the AuNP formation on the shell. A 70 μL solution at a concentration of 0.04 mg/mL AuNP@Qβ(Dox) was then irradiated with a single six nanosecond laser pulse at an energy density of 500 mJ/cm 2 and centered at a wavelength of 532 nm. The solution temperature was monitored using a thermocouple and no bulk solution temperature change was observed. Based upon fluorescence analysis of the irradiated sample, a 100% enhancement in fluorescence was seen, indicating that Dox was released from the capsid. Under control conditions, with no laser irradiation, no fluorescence change was observed because the Dox is tightly bound to the RNA (Figure 4 A-C) . In a second control, which uses convective heat, we found we could replicate these results by boiling AuNP@Qβ(Dox) in water for five minutes, which completely denatured and destroyed the viral capsule. At room temperature, however, the AuNP@Qβ(Dox) was stable for several hours and showed little variation in fluorescence. We conducted CD and DLS spectroscopic studies ( Figures 4D and S19 ) to determine if the photothermal energy was transferred to the protein. Specifically, we looked at samples of Qβ VLP with and without AuNPs to determine if any obvious change in the spectra of theses samples could be ascertained. When AuNP@Qβ was irradiated, a decrease and slight shift in molar ellipticity could be seen, indicating FIGURE 5 : A) MTT assay of cells treated with Qβ composites or free Dox and incubated to monitor cell viability after 4 hours. ** and *** denote P values of ≤ 0.01 and 0.001 respectively. Live cell images depicting Dox release after laser irradiation through a pinhole; white line indicates the perimeter of laser irradiation. B) Brightfield. C) Hoechst 34442 D) Dox. E) Merged images acquired with a 10× objective focused near the center of the plate immediately following laser exposure. Cells located close to the aperture experience the release of Dox into the cellular space while those further away do not exhibit the same release. changes in secondary structure and in nanoparticle absorbance ( Figure 4D ) indicating some precipitation of aggregates. On the other hand, in a control experiment Qβ VLP, which used laser irradiation at 1064 nm, no change was evident by DLS or agarose band shift ( Figures S19 and S21) . We thus attribute this heat to localized absorption of the laser light to generate thermal energy via localized surface plasmon resonance (LSPR), which in turn denatures the capsid proteins and providing sufficient thermal energy to release the Dox. This localized heat denaturation and drug causes a slight shift in the nanoparticle absorbance ( Figure  S20) , denaturation of the protein capsid and releasing the drug as shown by bandshift assays ( Figure S21 ) in agarose gel electrophoresis. To our knowledge, this is the first experimental proof of using nanoscale-confined protein denaturation to achieve highly localized and selective drug release.
In order to move toward studies in cellular systems, we first had to determine the toxicity of our particles via MTT assay using each of the Qβ constructs without the use of laser activation ( Figure 5A ). The assay showed no significant difference between Qβ(Dox), AuNP@Qβ and AuNP@Qβ(Dox) all of which have a p value of <0.001 in comparison to nQβ. A key advantage of this extreme confinement of thermal energy is that it should enable highly targeted release of therapeutics exclusively within the path of a focused beam of light. In other words, we should be able to pinpoint the cells we wish to kill in a single culture without affecting the surrounding cells owing to convective heat loss. To demonstrate the efficacy of our approach in vitro, cell studies were performed using RAW 264.7 macrophages. Three-centimeter glass bottom plates were seeded with ~1 × 10 6 cells 1-2 days prior to the experiment producing cells that reached ~80% confluency. The cells were then incubated with 240 µL of 0.2 mg/mL AuNP@Qβ(Dox) as well as appropriate controls for 4 h. The cells were then washed three times with PBS, stained with 200 nm Hoechst 34442 and washed again with PBS. The plates were covered with a cardboard mask pierced with an 18-gauge needle to confine the laser path to a diameter of 1.27 mm and demonstrate the specificity of release ( Figure 5B-E) . The cells were then subject to a single pulse of 500 mJ/cm 2 and immediately imaged by live-cell fluorescence microscopy. Immediately following laser irradiation, the release of Dox in the targeted "kill-zone" was obvious in the redchannel of our fluorescence microscope. The morphology of the cells, as shown in Figure 5E and in higher magnification (inset), did not immediately change following irradiation, indicating that the initial laser itself did not affect the cells (also shown in Figure S22 ). Fluorescence imaging, however, revealed extensive Dox release in the kill-zone with the correlation between cells showing release and those within the targeted area being very high.; outside of this area, no red fluorescence could be discerned. The highly targeted nature of laser irradiation makes bulk cell viability assays like MTT ineffective, thus we monitored cell viability via live-cell fluorescence imaging for 12 h. Cells outside the kill-zone remained intact, adherent, and their morphology was generally unchanged. Within the kill-zone, however, cell morphology became clearly different, and the resulting cells largely detached from the plate after 12 h ( Figure S23 ) indicating they were killed. When the experiment was repeated Figure  S24 ) demonstrating again, the release is attributed to highly localized optical excitation of the proteinaceous gold complex within the living cell.
CONCLUSION
Using the strong affinity between disulfides and gold species, we have shown that AuNPs can be site selectively synthesized in a controlled manner on the pore structures of Qβ through a simple incubation and reducing process. TEM micrographs show a well-ordered topology of AuNP@Qβ in accordance with the pattern of pores on Qβ. The growth of the nanoparticles is clearly dependent upon the existence of disulfides as reduction to free sulfurs or acylation of these sulfurs fails to yield the composite material. The resulting AuNP@Qβ is stable, when left exposed on the benchtop at RT for more than one month, even though the AuNPs themselves are prone to self-aggregation. Computational modeling indicates this stability arises from surface passivation by local protein physisorption. We found that the growth of AuNPs on the VLP is unaffected by loading the interior with the anti-cancer drug Doxorubicin. We successfully demonstrated that this new AuNP@Qβ(Dox) composite can release the Dox upon nanosecond pulsed irradiation without heating the bulk solution and thus offers a pathway to highly localized drug delivery. This proof-of-concept shows great promise in using laser irradiation to trigger the release of materials confined within proteinaceous capsids.
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VLP, Virus-Like Particle; Dox, Doxorubicin; AuNP, Gold Nanoparticle; CD, Circular Dichroism; MD, Molecular Dynamics; TEM, Transmission Electron Microscopy; PXRD, Powder X-Ray Diffraction; EPR, Enhanced Permeability and Retention. Materials. Tetrachloroauric (III) trihydrate (HAuCl4·3H2O: 99.9%) and sodium borohydride (NaBH4: 99%) were purchased from Sigma-Aldrich, Doxorubicin hydrochloride (C27H29NO11 • HCl) was purchased from Cayman Chemical Company. All reagents were used without further purification. All aqueous solutions were prepared using water from Millipore Milli-Q purification system (18.2 MΩ/cm). Qβ was prepared according to a previously reported method.
SYNOPSIS TOC (Word Style
1 Sephadex G-25 column was purchased from GE Healthcare.
Instruments: All the TEM (transmission electron microscopy) imaging was performed on a Tecnai™ G2 Spirit optical system. TEM samples were prepared by evaporating a drop of the sample solution on a carbon coated grid. Uranyl acetate solution (1%) was used as a negative stain. UV-vis spectra were recorded on a Shimadzu UV-1601PC UVvisible spectrophotometer. DLS data was obtained using a Malvern Zetasizer. Fluorescence spectra were recorded on LS50B Luminescence Spectrometer (PerkinElmer, Inc.). XRD data were collected using a Bruker D8 Advance powder Xray diffractometer operating at 40 kV and 30 mA with CuKa (1.54060 Å) radiation and a LYNXEYE XE detector. Laser experiments were performed using a Nd:YAG laser system (Quantel Q-smart 450) with a thermocouple manufactured by HH506A, Omega, USA. ICP-MS measurements we performed using an Agilent 7800 ICP triple Quadrupole MS. Fluorescence images were acquired using either an FV3000RS Confocal Microscope or a Life Technologies EVOS FL Auto Epifluorescence Microscope with 40 or 60 × objective. Gels were imaged using a Bio-Rad ChemiDoc MP Imaging System. Circular Dichroism data collected on an AVIV Circular Dichroism Spectrometer.
Synthesis of Gold Nanoparticles on Qβ.
In a solution of Qβ (0.2 mg/mL, 1 mL), 20 μL of HAuCl4 solution (50 mM) was added and mixed well. The mixture was incubated for 3 h at room temperature. Then 160 μL of NaBH4 (10 mM, freshly prepared and ice cold) solution was added to the Qβ and HAuCl4 solution with vigorous stirring for 5 min. The solution turned red in color immediately and was incubated without disturbance for 12 h at RT. The small amount of precipitated and free gold nanoparticles were removed by running the crude solution through a Sephadex G-25 column.
Alkylation of disulfides of Qβ.
A mixture containing 400 μL Qβ solution (1 mg/mL) and 100 μL of DTT solution (1 M) was incubated at 37 ℃ for 1 h. Next, 1 mL of 100 mg/mL iodoacetamide was added and the solution was again incubated at 37 ℃ for 1 h. The final reaction solution was desalted using a Sephadex G-25 column.
Synthesis of Qβ(Dox)-Au NPs: 300 μL of a Qβ solution (3.3 mg/mL) was mixed with a 200 μL Dox solution (1 mg/mL) and this mixture was allowed to sit at RT for 10 min. Free Dox was removed from the system by a Sephadex G-25 column. The collected Qβ(Dox) protein concentration was confirmed by Bradford assay. This solution of Qβ(Dox) at a concentration of 1 mg/mL was used in the synthesis of AuNPs on Qβ using the aforementioned method.
Laser irradiation:
The AuNP@Qβ(Dox) solution made above was diluted five-fold and 70 μL of this solution was used for each experiment. A sample was irradiated with a Nd:YAG laser system (Quantel Q-smart 450) operated at 532 nm and pulse duration of six nanoseconds (full width at half maximum, or FWHM). The sample was irradiated by single laser pulse at 500 mJ/cm 2 . This was repeated on five samples and the reported fluorescence and UV-vis spectra are reported as the average solution spectra from the experiment after five-fold dilution.
ICP-MS and Quantitation:
The AuNPs were diluted to a concentration of 0.0002 mg/ml in a 3% nitric and 2% hydrochloric acid aqueous solution. Each sample was analyzed for Au using both no Gas and Helium mode and compared against prepared gold standards (Inorganic Ventures) ranging from 12.5 ppb to 1000 ppb. 10 samples were measured in triplicate for each sample and averaged.
To calculate the number of gold nanoparticles per capsid, we first calculate the volume of a typical nanoparticle based on the TEM size and the equation for the volume of a sphere. This value is then divided why the known literature value for the volume of the gold unit cell, 0.0679 nm 3 , and subsequently multiplied by four as there are four gold atoms per unit cell. The result can be converted to molecules using Avogadro's number. ICP-MS data can be converted from ppb to molecules of gold and the number of Qβ capsids was calculated based on concentration used for analysis. The quotient of the number of available pores on all Qβ capsids to the Au measured yields the approximate number of particles assuming even distribution.
Circular Dichroism: Each sample was diluted to 0.4 mg/mL and subject to five pulses of laser irradiation (500 mJ/cm 2 ) each of which lasting six nanoseconds. The samples were mixed between each pulse. Three samples of each were measure in triplicate using an AVIV Circular Dichroism Spectrometer (Dynode Cutoff: 650 V, 180-260 nm) Ellman's Assay: To prepare Ellman's reagent solution, 4 mg of Ellman's reagent was added into 1 mL of Ellman's reagent buffer (0.1 M sodium phosphate buffer, 1mM EDTA, pH 8.00) 125 μL of Ellman's reagent was added into 6.25 mL of reagent buffer to make the working solution. 25 μL of nQβ and reoxidized Qβ (2 mg/mL) or cysteine standards (0 mM, 0.25 mM, 0.5 mM, 0.75 mM, 1.0 mM, 1.25 mM, 1.5 mM) was added into 255 μL of Ellman's working solution, followed by incubation at RT for 15 min before reading the absorbance at 412 nm. A standard curve was plotted ( Figure S5 ). The unfunctionalized cysteine concentrations of Qβ DB conjugates were obtained from the standard curve. The number of free thiols was calculated using the extinction coefficient of 2-nitro-5-thiobenzoic acid (TNB) -14,150M -1 cm -1 .
Dox Release in Agarose Gel:
Utilizing the same samples prepared for circular dichroism, samples were run in a 1% agarose gel using 1× TBE buffer for 1 h. For the time studies in Figure S20 , the cells were irradiated and placed in a live cell imaging setup and incubated at 37 °C and a 5% CO2 environment for 12 hours and imaged in one-hour increments. Figure S1 . Photographs of the Qβ@AuNP reaction procedure in the presence of Qβ (left) without Qβ (middle), and on alkylated Qβ (right). Figure S2 . Kinetic study performed using a 0.2 mg/mL of Qβ pre-incubated for 3 h with 50 mM HAuCl4. An absorbance scan was obtained every 5 min, the first point is representative of the VLPs incubated with 50 mM salts and the second point is immediately after the addition and mixing of NaBH4. Figure S19. DLS of as synthesized (blue line) and laser irradiated sample (green line) of different AuNP@Qβ samples utilizing a 532 nm six ns laser pulse to show the aggregation that occurs following irradiation. We see no change in the AuNP@Qβ samples using a 1064 nm laser (red line) as it does not interact with the surface plasmon of the gold. Each sample was diluted five times with MilliQ water and were subject to 10 pulses of the selected laser in a cuvette. 
Cell Experiments
Ancillary Figures:
Molecular Dynamics Simulations
Molecular dynamics simulations were carried out with the NAMD 2.10 2 (http://www.ks.uiuc.edu/Research/namd/) package using the CHARMM 27 all atom force field modified to include the nanoparticle. All simulations were initially energy minimized for 1000 steps. The simulations were then run in vacuo at 300 K with a 2-fs time step for a total time of 4 ns. A cutoff of 4.00 nm with a switching distance of 3.80 nm, and a pair list distance of 4.50 nm were used for the pair-wise (non-bonded) interactions (a large cutoff was necessary due to scale of the nanoparticle). No periodic boundary conditions were used.
Modeling the Gold Nanoparticle
Although the experimentally synthesized gold nanoparticles (AuNPs) are not truly spherical, we assumed they could be reasonably approximated as spheres. Therefore, the gold nanoparticle was modeled as a single site spherical "coarse grain" particle, which was added to the CHARMM force field using tabulated potentials. The nonbonded parameters were derived by minima matching of a non-standard Lennard-Jones (LJ) 80-40 potential, which is given by Eq. 1.
Eq (1) for particles i and j separated by a distance rij , to the potential energy between an all atom gold nanoparticle (aa-AuNP) and a carbon (CHARMM type C) atom. To generate an aa-AuNP, a slab of gold atoms was generated using the Inorganic Builder extension in VMD 3 (http://www.ks.uiuc.edu/Research/vmd). A diameter of 6.4 nm (the experimentally determined diameter plus one standard deviation) was used for the model nanoparticle, so a spherical selection of radius 3.2 nm was then cut from the center of the gold slab and used as the aa-AuNP. The potential energy between the aaAuNP and the single carbon atom was computed as a function of their center of mass separation (aa-AuNP rotational degrees of freedom were not included). In this calculation, the gold atom parameters (Lennard-Jones 12-6) determined by Verde et al. 4 were used with no cutoff; standard Berthelot mixing was used between gold atoms and the carbon atom. The LJ 80-40 potential was then fit to the potential energy curve with Rminaa-AuNP-C= 3.03555 nm and єaa-AuNP-C = 1.38759 kcal mol -1 . The fit is shown in Fig. 1 . The coarse-grained gold nanoparticle (cg-AuNP) parameters were then derived by assuming Berthelot mixing between the cg-AuNP and carbon atom LJ parameters: the values were determined to be σcg-AuNP = 57.8862 Å and εcg-AuNP = 17.5038 kcal mol -1 . The cg-AuNP LJ parameters were then mixed with each atom type in the system and the LJ 80-40 potential with mixed parameters was tabulated with 10000 points up to a maximum distance of 4.5 nm; linear interpolation was used for intermediate distances.
Figure S12
The van der Waals (vdW) energy between aa-AuNP and the CHARMM type C carbon atom as a function of their center of mass separation.
Simulating the cg-AuNP at the pore
A single hexameric and a single pentameric pore were chosen from the full virus structure. For each pore of interest, the pore and the surrounding region within ~12.0 nm of the pore center were cut out from the full viral capsid. One starting configuration of the cg-AuNP was then generated for each pore (two starting configurations in total): the nanoparticle was placed by hand near the pore in a position outside the capsid. A harmonic bond was added between the center of the cg-AuNP and each sulfur of the active pore, modeling a fully chemisorbed nanoparticle. The parameters used for the harmonic bond between the gold particle and the pore sulfurs were Kb = 100 kcal mol -1 Å -2 and b0 = 34.0 Å. The choice of force constant was somewhat arbitrary, but the bond length was chosen to be the cg-AuNP radius plus an additional 2 angstroms (which is roughly the length of a gold atom to sulfur bond). In order to reduce the computation time, only the positions of the gold particle and viral segments in the immediate region of the pore were integrated, while the other protein atoms were fixed. The selections are shown in S13.
Figure S13
Hexameric (Left) and pentameric (Right) pore selections used for simulations. The pore sulfurs (in yellow) and the surrounding segments (in green) were allowed to move during the simulations, while the outer segments (in red) were fixed.
Measuring the pore diameter
A relatively simple minimum cone angle measurement was used to approximate the pore size (without including atom size effects). In this scheme the maximum crosssectional diameter of a cone that just overlaps an atom center is computed. A vector is determined between the geometric center of the pore sulfurs (assumed to be the pore center) and a radially central reference point. The reference point was taken as the geometric center of the fixed atoms with distance greater than 10 nm from the cg-AuNP center in the initial configuration. Then a selection of atoms (not including the cg-AuNP) within 0.20 nm of the sulfur center was selected. For each of the selected atoms, a vector was computed from the reference point to the atom center, and the angle between that vector and the pore center vector was computed. The minimum angle was determined and was subsequently used to compute the corresponding circular cross section diameter of the cone. The measurement is graphically depicted in S14. Figure S14 . Depiction of the minimum cone angle measurement used to approximate the pore size.
Measuring the Percent protected Surface Area of the cg-AuNP
We used a Monte Carlo routine to measure the relative amount of the cg-AuNP surface area that is protected by the surrounding proteins. First the coordinates of protein atoms within 3.5 nm of the cg-AuNP center were projected onto the surface of the cg-AuNP (with radius 3.2 nm). An example selection is shown in S15 Figure S15 . cg-AuNP and the selection of atoms within a distance of 3.5 nm from its center.
The Monte Carlo trial moves consisted of randomly placing a point on the surface of the cg-AuNP. These points were flagged as accepted if they did not overlap any atoms. All atoms were assigned a uniform radius of 0.25 nm (roughly the size of a carbon atom). A total number of trial moves n t = 20000 was used and the number of accepted trial moves n a was recorded. The Percent protected Surface Area (PSA) was computed from the acceptance ratio f a =n a n t ⁄ using Eq. 2.
PSA=(1 − f a )4πr cg-AuNP 2 * 100 Eq (2) cg-AuNP at the pentameric pore
As seen in Figure S13 , a 6.4 nm cg-AuNP was modeled at the pentameric pore. The cgAuNP was bound to the ten sulfurs of the pentameric pore structure. The cg-AuNP seemed to have a larger effect on the local structure of the pentameric pore than was observed in the hexameric pore. By the end of the simulation the diameter of the pentameric pore had nearly doubled. However, the cg-AuNP did not embed very deep into the pore structure. Only about 9% of the nanoparticle's surface area was protected by the pore proteins. That is less than half of the protected area measured for the hexameric pore (~23%), which suggests that AuNPs at pentameric pores would likely not be stabilized as well as those at hexameric pores.
Effect on the critical size of partially protecting AuNPs
As noted in the main text, 6 nm naked gold nanoparticles (AuNPs) are unstable and subject to rapid Ostwald ripening, which causes precipitation [main text citations 41, 42] . Being partially embedded in the virus coat protein seems to offer additional stability and protection for these AuNPs. Since the AuNPs were modeled as spheres in the MD simulations, we compare both the simulation and experimental results to classical nucleation theory of spherical particles.
From classical nucleation theory, the free energy associated with a spherical nanoparticle of radius r is given by Eq. 3, ΔG(r) = − In Eq. 5 the interfacial free energy cost due to the surface area of the nanoparticle is split into two components: one for the nanoparticle-solvent contribution, and one for the nanoparticle-protectant contribution. Likewise, the new critical radius is given by Eq. 6. 
Eq. 6
Now we can take the difference between the two critical radii (Eqs. 4 and 6), which is given in Eq. 7.
Δr=r sp -r s = 2f p (γ p −γ s ) ΔG V
Eq. 7
We can define the protectant to have a favorable interaction with the nanoparticle, such that the nanoparticle has a lower interfacial tension with the protectant than with the solvent (i.e. (γ p − γ s ) < 0). In this case, the difference in critical radii will be less than zero (i.e. Δr<0), which would imply that the nanoparticle with protectant is stable at a smaller radius than the bare nanoparticle in solvent.
The simulation results suggest that AuNPs at Qβ pores would be afforded a fair amount of protection by the surrounding pore proteins; ~23% of the surface area was protected in the model system for the 6.4 nm cg-AuNP at the hexameric pore and ~9% for the same particle at the pentameric pore. From experiments, the bare AuNPs that precipitated from solution had a diameter of 48 ± 10 nm, while those at the Qβ pores had a diameter of 6.2 ± 0.2 nm. Assuming those diameters correspond to the critical radii, we can compute the difference in the critical radius to be Δr ≈ −20 nm. This is a rather large reduction in the size of nanoparticles, which is consistent with the pore proteins acting as a strong protectant for those AuNPs bound to them.
